All lobbying filings

CVS Health (And Subsidiaries)

CVS Health (And Subsidiaries) filed a Q1 report for CVS Health (And Subsidiaries) on April 21, 2025.

Lobbying for CVS Health (And Subsidiaries) · Health Care

As filed: CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES).

All filings by CVS Health (And Subsidiaries) · Everything CVS Health (And Subsidiaries) has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$3,460,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

TARA ROUNTREE New on this filing

Previously held: Chief of Staff, Rep. Jennifer McClellan; Chief of Staff, VA-04 Congressional District; Chief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Donald McEachin; Scheduler, Rep. Donald McEachin

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 6

Pharmacy

Issues related to retail pharmacy, drug pricing, and women's health.

Taxation/Internal Revenue Code

Issues related to corporate tax.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. S. 882, the Patients Before Middlemen (PBM) Act S. 927, the Protecting Pharmacies in Medicaid Act H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. S.Con.Res.7 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034

Insurance

Issues related to employer, small group and individual insurance markets. S. 864, the Help Ensure Lower Patients (HELP) Copays Act H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act

Labor Issues/Antitrust/Workplace

Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues.

Consumer Issues/Safety/Products

Issues related to organized retail crime.

Bills named in this filing 7

S. 882
Patients Before Middlemen Act
S. 927
Protecting Pharmacies in Medicaid Act
H.R. 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
H. Con. Res. 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
S. Con. Res. 7
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal ye…
S. 864
HELP Copays Act
H.R. 2214
DRUG Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.